Despite high borrowing costs and extended hold times in 2024, dealmaking roared ahead for healthcare private equity with a ...

Despite the pause, the company clarified that the suspension does not impact commercial activity outside the US.

Leuven, Belgium-based Capricorn Partners, announced the first close of its Capricorn Health-tech Fund II at €51M.

Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it has raised US$11 million in Series A funding ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

Investors may have flocked to health care AI companies in recent years, but funding has leveled off and backers are "becoming ...

Bernstein raised the firm’s price target on Stryker (SYK) to $425 from $410 and keeps an Outperform rating on the shares as part of a broader ...

Bernstein raised the firm’s price target on Insulet (PODD) to $315 from $305 and keeps an Outperform rating on the shares as part of a broader ...

Bernstein raised the firm’s price target on DexCom (DXCM) to $89 from $86 and keeps an Outperform rating on the shares as part of a broader ...

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...

FlowBeams, creator of the BoldJet needle-free injection showcased itsbreakthrough medtech technology at CES 2025.The company’s innovative needle-free injection ...

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.